Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-06 Dake Benjamin T SEE REMARKS Sale 10b5-1 −10,283 $16.11 $166K 1,291
2023-12-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −905 906
2023-12-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,506 12,055
2023-12-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,019 16,294
2023-12-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −6,853 123,346
2023-12-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +1,400 $1.74 $2K 3,009
2023-12-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +3,200 $2.14 $7K 6,209
2023-12-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −4,600 $16.30 $75K 1,609
2023-12-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −900 15,108
2023-12-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −500 10,088
2023-12-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −500 11,894
2023-12-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,200 37,308
2023-12-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,500 44,732
2023-11-27 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +2,413 $1.74 $4K 3,704
2023-11-27 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +10,104 $2.14 $22K 13,808
2023-11-27 Dake Benjamin T SEE REMARKS Sale 10b5-1 −12,517 $16.24 $203K 1,291
2023-11-27 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −906 1,811
2023-11-27 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,507 13,561
2023-11-27 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,018 17,313
2023-11-27 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −9,086 130,199

Page 11 of 16 · 315 trades